Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus
- PMID: 25551104
- PMCID: PMC4279910
- DOI: 10.1186/s40200-014-0125-y
Paraoxonase-1 gene Q192R and L55M polymorphisms and risk of cardiovascular disease in Egyptian patients with type 2 diabetes mellitus
Abstract
Background: Increased oxidative stress or an impaired antioxidant defense mechanism may play a crucial role in the onset and progression of atherosclerosis. Recently, Paraoxonase -1 (PON1) which accounts for most of the antioxidant effect of high density lipoprotein (HDL) cholesterol has been presented as a potential therapeutic agent against atherosclerosis development. Allele frequencies for PON1 gene that influence enzyme concentration as well as activity differ greatly among ethnic groups and data from several studies showed ethnic variations in the interpretation of cardiovascular disease (CVD) associated with PON1 polymorphisms. In this work, we investigated PON1 Q192R and L55M polymorphisms in Egyptian patients with type 2 diabetes mellitus (T2DM) and its association with CVD.
Methods: The study included 184 subjects classified into 3 groups; T2DM, T2DM + CVD, and healthy controls. PON1 polymorphisms were genotyped by real-time PCR and PON1 concentration was assayed in serum by ELISA (enzyme linked immunesorbent assay).
Results: Genotype and allele frequencies of Q192R were significantly different between controls and diabetic patients. Frequency of QQ genotype was significantly higher in healthy controls, while QR and RR genotypes were significantly higher in diabetic patients (p = 0.02). Frequency of 55LL and LM genotypes were significantly higher in patients than in controls (p = 0.009). Q192R polymorphism associated with CVD in our diabetic patients (p = 0.01) and with low serum PON1 concentration (p = 0.04). Multiple logistic regression analysis revealed significant correlations between 192R and other independent CVD risk factors.
Conclusion: PON1 192R and 55 L alleles are associated with T2DM. Q192R polymorphism is associated with CVD and lower serum enzyme concentration and might represents a novel risk factor for CVD in Egyptian patients with T2DM.
Keywords: Cardiovascular disease; Paraoxonase-1 gene; Type 2 diabetes mellitus.
Similar articles
-
Paraoxonase 1 (PON1) L55M and Q192R polymorphisms are not associated with chronic kidney disease in Thai individuals with type 2 diabetes.Int J Clin Pract. 2021 Dec;75(12):e14982. doi: 10.1111/ijcp.14982. Epub 2021 Oct 20. Int J Clin Pract. 2021. PMID: 34637171
-
The association of paraoxonase I gene polymorphisms Q192R (rs662) and L55M (rs854560) and its activity with metabolic syndrome components in fars ethnic group.Horm Mol Biol Clin Investig. 2023 Feb 17;44(3):295-303. doi: 10.1515/hmbci-2022-0064. eCollection 2023 Sep 1. Horm Mol Biol Clin Investig. 2023. PMID: 36793191
-
Serum paraoxonase-1 (PON1) activities (PONase/AREase) and polymorphisms in patients with type 2 diabetes mellitus in a North-West Indian population.Gene. 2011 Nov 1;487(1):88-95. doi: 10.1016/j.gene.2011.07.011. Epub 2011 Jul 26. Gene. 2011. PMID: 21803130
-
The most effective polymorphisms of paraoxonase-1 gene on enzyme activity and concentration of paraoxonase-1 protein in type 2 diabetes mellitus patients and non-diabetic individuals: A systematic review and meta-analysis.Diabetes Res Clin Pract. 2019 Jun;152:135-145. doi: 10.1016/j.diabres.2019.05.007. Epub 2019 May 15. Diabetes Res Clin Pract. 2019. PMID: 31102685
-
Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis.Neurol Sci. 2015 Jan;36(1):11-20. doi: 10.1007/s10072-014-1979-y. Epub 2014 Oct 10. Neurol Sci. 2015. PMID: 25301263 Review.
Cited by
-
Association between paraoxonase-1 gene Q192R and L55M polymorphisms in systemic lupus erythematosus (SLE) and anti-phospholipid syndrome (APS) in a population from Cairo of Egypt.Clin Rheumatol. 2017 Jun;36(6):1305-1310. doi: 10.1007/s10067-017-3567-z. Epub 2017 Feb 9. Clin Rheumatol. 2017. PMID: 28185016
-
Single-nucleotide polymorphisms as important risk factors of diabetes among Middle East population.Hum Genomics. 2022 Apr 2;16(1):11. doi: 10.1186/s40246-022-00383-2. Hum Genomics. 2022. PMID: 35366956 Free PMC article. Review.
-
The Associations between Paraoxonase 1 L55M/Q192R Genetic Polymorphisms and the Susceptibilities of Diabetic Macroangiopathy and Diabetic Microangiopathy: A Meta-Analysis.Diabetes Ther. 2018 Aug;9(4):1669-1688. doi: 10.1007/s13300-018-0466-5. Epub 2018 Jul 9. Diabetes Ther. 2018. PMID: 29987647 Free PMC article.
-
Expression of JAZF1, ABCC8, KCNJ11and Notch2 genes and vitamin D receptor polymorphisms in type 2 diabetes, and their association with microvascular complications.Ther Adv Endocrinol Metab. 2017 Jun;8(6):97-108. doi: 10.1177/2042018817708910. Epub 2017 Jun 5. Ther Adv Endocrinol Metab. 2017. PMID: 28794851 Free PMC article.
-
Effects of paraoxonase 1 gene polymorphisms on heart diseases: Systematic review and meta-analysis of 64 case-control studies.Medicine (Baltimore). 2016 Nov;95(44):e5298. doi: 10.1097/MD.0000000000005298. Medicine (Baltimore). 2016. PMID: 27858903 Free PMC article.
References
-
- Diabetes Action Now. An Initiative of the World Health Organization and the International Diabetes Federation 2004 [http://www.who.int/diabetes/actionnow/en/DANbooklet.pdf]
-
- Chaudhary R, Likidlilid A, Thavatchai Peerapatdit T, Damras Tresukosol D, Srisuma S, Ratanamaneechat S, Sriratanasathavorn C. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease. Cardiovasc Diabetol. 2012;11:36–47. doi: 10.1186/1475-2840-11-36. - DOI - PMC - PubMed
-
- Sahin I. HDL-C as a new therapeutic target in the treatment of dyslipidemia. Med Sci. 2012;1(2):141–149. doi: 10.5455/medscience.2012.01.141-149. - DOI
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous